Category - Executive Moves

Executive Moves

3DS names Dr. Kevin Little as CSO

3D Signatures (OTCQB:TDSGF; TSXV:DXD; FSE:3D0) appointed Dr. Kevin Little, a leading biomedical scientist and corporate executive, as its new chief scientific officer, effective immediately.

April 11, 2017

Executive Moves

John Calcagnini joins Stout as managing director

John Calcagnini has joined Stout Risius Ross as managing director in the investment banking group’s healthcare industry practice.

March 14, 2017

Executive Moves

Harry Glorikian joins 3D Signatures BAD

3D Signatures (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) has appointed Harry Glorikian to its business advisory board.

February 16, 2017

Executive Moves

Stereotaxis taps investor exec David Fischel as acting CEO

Stereotaxis (NASDAQ:STXS) announced a senior management change in a move designed to help re-establish the company’s growth trajectory.

February 8, 2017

Executive Moves

BioTime appoints Stephana Patton as general counsel

BioTime (NYSE MKT:BTX) has appointed Stephana Patton as general counsel, a newly created position. Reporting in her new role to Adi Mohanty, co-CEO, Dr. Patton will oversee all legal matters at the company.

February 7, 2017

Executive Moves

Richard Glickman adds CEO title at Aurinia

Richard Glickman, founder and chairman of Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP), was named to the added post of CEO. The board also accepted the resignation of Charles Rowland as CEO and an executive member of...

February 7, 2017

Executive Moves

Hugh Rogers joins RepliCel board

RepliCel Life Sciences (OTCQB:REPCF; TSX-V:RP) appointed Hugh Rogers to its board.

February 6, 2017

Executive Moves

Kenneth Galbraith joins Profound Medical board

Kenneth Galbraith, an accomplished life sciences industry veteran, has been appointed a director of Profound Medical (TSX-V:PRN). Mr. Galbraith has over 25 years of experience as an executive, director, investor and...

January 18, 2017

Executive Moves

Profound Medical COO joins XOR-Labs board

Steven Plymale, president and COO of Profound Medical (TSX-V:PRN), has been appointed an independent director of XOR-Labs, a spinoff from Toronto General Hospital at University Health Network, the world's leading center...

January 17, 2017

Executive Moves

HCW names John Chambers president, head investment banking

John Chambers has joined H.C. Wainwright as president and head of investment banking. Mr. Chambers joins HCW from Roth Capital Partners where he was vice chairman and head of healthcare investment banking. In his 28...

January 9, 2017

Category - Executive Moves

General

More